FBInvestor
Stocks / Bright Minds Biosciences Inc
Institutional Ownership

Bright Minds Biosciences Inc

CUSIP 10919W405COM NEWDRUGQ1 2026

13D / 13G Filings
30
Schedule 13D/13G on record
Beneficial Filers
15
Distinct reporting persons
Largest Stake
30.6%
Max % of class reported
Institutional Holders
90
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

30 filings · latest Feb 17, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Feb 17, 2026Commodore Capital LP13G/A11.0%18.9KSEC
2Feb 17, 2026Janus Henderson Group PLC13G/A14.9%1.16MSEC
3Feb 17, 2026Perceptive Advisors LLC13G/A4.6%449.3KSEC
4Feb 6, 2026Cormorant Asset Management, LP13G/A10.9%1.06MSEC
5Nov 14, 2025Vivo Opportunity Fund Holdings, L.P.13G6.4%454.2KSEC
6Nov 13, 2025Adage Capital Management, L.P.13G5.6%395.7KSEC
7Nov 12, 2025Sio Capital Management, LLC13G/A2.7%190.8KSEC
8Aug 14, 2025Janus Henderson Group PLC13G/A16.3%1.15MSEC
9Aug 13, 2025Sio Capital Management, LLC13G/A7.3%512.3KSEC
10May 15, 2025Ra Capital Management, L.P.13G/A2.9%206.4KSEC

20 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Bright Minds Biosciences Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →